The Multiple Faces of Valosin-Containing Protein-Associated Diseases: Inclusion Body Myopathy with Paget’s Disease of Bone, Frontotemporal Dementia, and Amyotrophic Lateral Sclerosis

[1]  J. Tehranzadeh,et al.  Radiological features of Paget disease of bone associated with VCP myopathy , 2012, Skeletal Radiology.

[2]  W. Seeley,et al.  Inclusion body myopathy with Paget disease of bone and frontotemporal dementia linked to VCP p.Arg155Cys in a Korean family. , 2011, Archives of neurology.

[3]  M. Passos-Bueno,et al.  A Brazilian family with hereditary inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia. , 2011, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[4]  M. Rossor,et al.  A novel exon 2 I27V VCP variant is associated with dissimilar clinical syndromes , 2011, Journal of Neurology.

[5]  Henry C. Chang,et al.  Pathogenic VCP/TER94 Alleles Are Dominant Actives and Contribute to Neurodegeneration by Altering Cellular ATP Level in a Drosophila IBMPFD Model , 2011, PLoS genetics.

[6]  Patrizia Sola,et al.  Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS , 2011, Neuron.

[7]  E. Roberson.  Contemporary approaches to Alzheimer's disease and frontotemporal dementia. , 2011, Methods in molecular biology.

[8]  C. Shaw,et al.  Capturing VCP: Another Molecular Piece in the ALS Jigsaw Puzzle , 2010, Neuron.

[9]  J. Hodges,et al.  Frontotemporal dementias: Recent advances and current controversies , 2010, Annals of Indian Academy of Neurology.

[10]  D. Wallace,et al.  VCP Associated Inclusion Body Myopathy and Paget Disease of Bone Knock-In Mouse Model Exhibits Tissue Pathology Typical of Human Disease , 2010, PloS one.

[11]  C. Bendotti,et al.  A role of small heat shock protein B8 (HspB8) in the autophagic removal of misfolded proteins responsible for neurodegenerative diseases , 2010, Autophagy.

[12]  C. Bendotti,et al.  The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS). , 2010, Human molecular genetics.

[13]  C. Stefanski,et al.  Excessive collagen accumulation in dystrophic (mdx) respiratory musculature is independent of enhanced activation of the NF-κB pathway , 2010, Journal of the Neurological Sciences.

[14]  Huilin Zhou,et al.  ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS , 2010, Proceedings of the National Academy of Sciences.

[15]  Peter M. A. Sloot,et al.  Comparison of HIV-1 Genotypic Resistance Test Interpretation Systems in Predicting Virological Outcomes Over Time , 2010, PloS one.

[16]  A. Cuervo,et al.  Autophagy gone awry in neurodegenerative diseases , 2010, Nature Neuroscience.

[17]  G. Siciliano,et al.  The role of autophagy: what can be learned from the genetic forms of amyotrophic lateral sclerosis. , 2010, CNS & neurological disorders drug targets.

[18]  L. Murri,et al.  Clinical trials for neuroprotection in ALS. , 2010, CNS and Neurological Disorders - Drug Targets.

[19]  J. Trojanowski,et al.  TDP-43 Mediates Degeneration in a Novel Drosophila Model of Disease Caused by Mutations in VCP/p97 , 2010, The Journal of Neuroscience.

[20]  A. Buchberger,et al.  Imbalances in p97 co‐factor interactions in human proteinopathy , 2010, EMBO reports.

[21]  F. Mastaglia,et al.  Two Australian families with inclusion-body myopathy, Paget’s disease of bone and frontotemporal dementia: Novel clinical and genetic findings , 2010, Neuromuscular Disorders.

[22]  A. Wright,et al.  Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone. , 2010, Human molecular genetics.

[23]  J. Ju,et al.  Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy. , 2010, Human molecular genetics.

[24]  D. Cleveland,et al.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. , 2010, Human molecular genetics.

[25]  P. Leigh,et al.  Motor neuron disease: Focusing the mind on ALS: updated practice parameters , 2010, Nature Reviews Neurology.

[26]  S. Bhatnagar,et al.  Therapeutic targeting of signaling pathways in muscular dystrophy , 2010, Journal of Molecular Medicine.

[27]  Charles D. Smith,et al.  Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts , 2009, Neuromuscular Disorders.

[28]  S. Engelborghs,et al.  Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159His , 2009, Neurology.

[29]  M. Hernán,et al.  Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population‐based study , 2009, European journal of neurology.

[30]  N. Bresolin,et al.  Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation , 2009, Neurobiology of Aging.

[31]  A. Pestronk,et al.  Valosin-containing protein disease: Inclusion body myopathy with Paget’s disease of the bone and fronto-temporal dementia , 2009, Neuromuscular Disorders.

[32]  K. Claeys,et al.  Clinical outcome in 19 French and Spanish patients with valosin-containing protein myopathy associated with Paget’s disease of bone and frontotemporal dementia , 2009, Neuromuscular Disorders.

[33]  C. Smart,et al.  Inclusion body myopathy with Paget disease and frontotemporal dementia (IBMPFD): clinical features including sphincter disturbance in a large pedigree , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.

[34]  A. Djamshidian,et al.  A novel mutation in the VCP gene (G157R) in a german family with inclusion‐body myopathy with paget disease of bone and frontotemporal dementia , 2009, Muscle & nerve.

[35]  Xun Hu,et al.  Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.

[36]  J L Haines,et al.  Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .

[37]  D. Rubinsztein,et al.  Autophagy Inhibition Compromises Degradation of Ubiquitin-Proteasome Pathway Substrates , 2009, Molecular cell.

[38]  V. Kimonis,et al.  VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder. , 2008, Biochimica et biophysica acta.

[39]  R. Deshaies,et al.  UBXD7 Binds Multiple Ubiquitin Ligases and Implicates p97 in HIF1α Turnover , 2008, Cell.

[40]  Xun Hu,et al.  TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.

[41]  Charles D. Smith,et al.  Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia , 2008, American journal of medical genetics. Part A.

[42]  S. DeKosky,et al.  Frontotemporal dementia associated with a Valosin‐Containing Protein mutation: report of three families , 2008 .

[43]  Richard I. Morimoto,et al.  Adapting Proteostasis for Disease Intervention , 2008, Science.

[44]  A. Kakizuka.  Roles of VCP in human neurodegenerative disorders. , 2008, Biochemical Society transactions.

[45]  H. Stenmark,et al.  ESCRTing autophagic clearance of aggregating proteins , 2008 .

[46]  A. Broccolini,et al.  An Italian family with inclusion‐body myopathy and frontotemporal dementia due to mutation in the VCP gene , 2008, Muscle & nerve.

[47]  E. Beghi,et al.  Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[48]  D. Drachman,et al.  Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia , 2007, Clinical genetics.

[49]  A. Danek,et al.  Brain imaging and neuropsychology in late-onset dementia due to a novel mutation (R93C) of valosin-containing protein. , 2007, Clinical neuropathology.

[50]  J. Morris,et al.  TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. , 2007, The American journal of pathology.

[51]  M. Hamshere,et al.  Identification of a Novel Valosin-Containing Protein Polymorphism in Late-Onset Alzheimer’s Disease , 2007, Neurodegenerative Diseases.

[52]  Sara E. Miller,et al.  Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice. , 2007, Human molecular genetics.

[53]  K. L. Gardner,et al.  Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. , 2007, The Journal of clinical investigation.

[54]  Hanns Lochmüller,et al.  The ubiquitin-selective chaperone CDC-48/p97 links myosin assembly to human myopathy , 2007, Nature Cell Biology.

[55]  G. Warren,et al.  Targeted deletion of p97 (VCP/CDC48) in mouse results in early embryonic lethality. , 2007, Biochemical and biophysical research communications.

[56]  E. Wanker,et al.  Pathological consequences of VCP mutations on human striated muscle. , 2007, Brain : a journal of neurology.

[57]  B. Delabarre,et al.  Central pore residues mediate the p97/VCP activity required for ERAD. , 2006, Molecular cell.

[58]  S. Ralston,et al.  Mechanisms of Disease: genetics of Paget's disease of bone and related disorders , 2006, Nature Clinical Practice Rheumatology.

[59]  S. Dalal,et al.  Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation. , 2006, Human molecular genetics.

[60]  F. Zimprich,et al.  Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP gene , 2005, Neurology.

[61]  Jacques P. Brown,et al.  Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. , 2005, The New England journal of medicine.

[62]  E. Schleicher,et al.  The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy , 2005, Acta Neuropathologica.

[63]  K. Fliessbach,et al.  Mutant valosin‐containing protein causes a novel type of frontotemporal dementia , 2005, Annals of neurology.

[64]  Sankar Ghosh,et al.  Signaling to NF-kappaB. , 2004, Genes & development.

[65]  B. Aggarwal,et al.  Nuclear factor-kappaB: the enemy within. , 2004, Cancer cell.

[66]  Changcheng Song,et al.  Molecular perspectives on p97-VCP: progress in understanding its structure and diverse biological functions. , 2004, Journal of structural biology.

[67]  A. Pestronk,et al.  Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein , 2004, Nature Genetics.

[68]  M. Matsui,et al.  In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. , 2003, Molecular biology of the cell.

[69]  A. Pestronk,et al.  Clinical and genetic heterogeneity in chromosome 9p associated hereditary inclusion body myopathy: exclusion of GNE and three other candidate genes , 2003, Neuromuscular Disorders.

[70]  B. Miller,et al.  Are amyotrophic lateral sclerosis patients cognitively normal? , 2003, Neurology.

[71]  R. Caselli,et al.  Cognitive impairment, frontotemporal dementia, and the motor neuron diseases , 2003, Annals of neurology.

[72]  Ruth Geiss-Friedlander,et al.  Protein Dislocation from the Endoplasmic Reticulum – Pulling Out the Suspect , 2002, Traffic.

[73]  K. Fröhlich,et al.  AAA-ATPase p97/Cdc48p, a Cytosolic Chaperone Required for Endoplasmic Reticulum-Associated Protein Degradation , 2002, Molecular and Cellular Biology.

[74]  Tom A. Rapoport,et al.  The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol , 2001, Nature.

[75]  Mark A. Levenstien,et al.  Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. , 2001, Molecular genetics and metabolism.

[76]  S. Jentsch,et al.  Mobilization of Processed, Membrane-Tethered SPT23 Transcription Factor by CDC48UFD1/NPL4, a Ubiquitin-Selective Chaperone , 2001, Cell.

[77]  Chou-Chi H. Li,et al.  Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin–proteasome degradation , 2001, Nature Cell Biology.

[78]  J. Trojanowski,et al.  Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia , 2001, Annals of neurology.

[79]  Murray Grossman,et al.  Quantitative neurohistological features of frontotemporal degeneration , 2000, Neurobiology of Aging.

[80]  S. Leal,et al.  Clinical and molecular studies in a unique family with autosomal dominant limb-girdle muscular dystrophy and Paget disease of bone , 2000, Genetics in Medicine.

[81]  D. Pappin,et al.  A complex of mammalian Ufd1 and Npl4 links the AAA‐ATPase, p97, to ubiquitin and nuclear transport pathways , 2000, The EMBO journal.

[82]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[83]  Hisao Kondo,et al.  Syntaxin 5 Is a Common Component of the NSF- and p97-Mediated Reassembly Pathways of Golgi Cisternae from Mitotic Golgi Fragments In Vitro , 1998, Cell.

[84]  D. Longo,et al.  Involvement of Valosin-containing Protein, an ATPase Co-purified with IκBα and 26 S Proteasome, in Ubiquitin-Proteasome-mediated Degradation of IκBα* , 1998, The Journal of Biological Chemistry.

[85]  D. Longo,et al.  Involvement of valosin-containing protein, an ATPase Co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha. , 1998, The Journal of biological chemistry.

[86]  Hisao Kondo,et al.  p47 is a cofactor for p97-mediated membrane fusion , 1997, Nature.

[87]  T. Koepsell,et al.  Incidence of amyotrophic lateral sclerosis in three counties in western Washington state , 1996, Neurology.

[88]  W. Murphy,et al.  Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone. , 1996, The Journal of clinical endocrinology and metabolism.

[89]  Raymond Scott Turner,et al.  Clinical, neuroimaging, and pathologic features of progressive nonfluent aphasia , 1996, Annals of neurology.

[90]  F. Confalonieri,et al.  A 200‐amino acid ATPase module in search of a basic function , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.